| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2006;82:879-888
© 2006 The Society of Thoracic Surgeons
a Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland
b Division of Radiology, The Johns Hopkins Medical Institutions, Baltimore, Maryland
Accepted for publication April 3, 2006.
* Address correspondence to Dr Conte, Division of Cardiac Surgery, Heart and Lung Transplantation, Johns Hopkins Medical Institutions, Blalock 618, 600 N Wolfe St, Baltimore, MD 21287. (Email: jconte{at}csurg.jhmi.jhu.edu).
Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30–Feb 1, 2006.
BACKGROUND: Surgical ventricular restoration (SVR) is an established therapy for congestive heart failure due to ischemic cardiomyopathy. Pulmonary hypertension (PHTN) has been considered a contraindication for SVR owing to a presumed increase in operative risk. However, outcomes in these patients and the impact of SVR on PHTN have not been specifically evaluated.
METHODS: We retrospectively reviewed SVR patients between January 2002 and June 2005. Patients were classified as PHTN (mean pulmonary artery pressure 
25 mm Hg) and no PHTN (mPAP < 25 mm Hg) based on preoperative cardiac catheterization. Cardiac function was assessed using magnetic resonance imaging and echocardiography. Follow-up was 100%.
RESULTS: Sixty-nine patients underwent SVR for congestive heart failure. Thirty-six percent (25 of 69) had preoperative PHTN. Preoperatively, PHTN patients had significantly lower ejection fraction (21.1% versus 30.0%; p = 0.005) and larger left ventricular end-systolic volume index (119.0 versus 88.7 mL/m2; p = 0.04) than patients without PHTN. All PHTN patients and 95.5% (42 of 44) of the no PHTN group were New York Heart Association (NYHA) class III/IV preoperatively. There was 1 operative death in the PHTN group. Surgical ventricular restoration significantly improved cardiac function and pulmonary pressures for PHTN patients. Both groups had similar cardiac function postoperatively. Seventy-two percent (18 of 25) of PHTN patients and 69.0% (29 of 42) of patients without PHTN improved to NYHA class I/II at follow-up. Kaplan-Meier survival of PHTN patients was 68.1% at 3 years, which was lower than patients without PHTN (81.4%; p = 0.44), but not statistically significant. Kaplan-Meier 3-year survival for all SVR patients was 76.6%.
CONCLUSIONS: Surgical ventricular restoration is a good treatment option in patients with advanced congestive heart failure and PHTN. Our early results are promising and should prompt further studies to confirm these findings.
This article has been cited by other articles:
|
|
 |
|
  R. B. Prucz, E. S. Weiss, N. D. Patel, L. U. Nwakanma, A. S. Shah, and J. V. Conte The Impact of Surgical Ventricular Restoration on Mitral Valve Regurgitation Ann. Thorac. Surg., September 1, 2008; 86(3): 726 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Patel, L. U. Nwakanma, E. S. Weiss, J. A. Williams, and J. V. Conte Impact of Septal Myocardial Infarction on Outcomes After Surgical Ventricular Restoration Ann. Thorac. Surg., January 1, 2008; 85(1): 135 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Patel, J. A. Williams, L. U. Nwakanma, E. S. Weiss, and J. V. Conte Impact of Lateral Wall Myocardial Infarction on Outcomes After Surgical Ventricular Restoration Ann. Thorac. Surg., June 1, 2007; 83(6): 2017 - 2028. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
